Redifferentiation of smooth muscle cells after coronary angioplasty determined via myosin heavy chain expression

Circulation

Volumn 96, Issue 1, 1997, Pages 82-90

  Aikawa, Masanori ^d   Sakomura, Yasunari ^e   Ueda, Makiko ^c   Kimura, Kenjiro ^e   Manabe, Ichiro ^e   Ishiwata, Sugao ^a   Komiyama, Nobuyuki ^a   Yamaguchi, Hiroshi ^e   Yazaki, Yoshio ^e   Nagai, Ryozo ^b  

^a TORANOMON HOSPITAL   (Japan)

^b GUNMA UNIVERSITY   (Japan)

^c OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e NONE

Author keywords

Angioplasty; Coronary disease; Muscle, smooth; Myosin; Restenosis

Indexed keywords

ALPHA ACTIN; ANTIBODY; MYOSIN HEAVY CHAIN;

ACUTE HEART INFARCTION; ADULT; AGED; ANGINA PECTORIS; ANGIOGRAPHY; ARTICLE; ATHERECTOMY; CELL DIFFERENTIATION; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; FEMALE; HEALING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTIMA; MALE; PHENOTYPE; PRIORITY JOURNAL; RESTENOSIS; SMOOTH MUSCLE FIBER; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0030792016     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.1.82     Document Type: Article

References (58)

1. Holmes DR Jr, Vlietstra RE, Smith HC, Vetrovec GW, Kent KM, Cowley MJ, Faxon DP, Gruenzig AR, Kelsey SF, Detre KM, Van Raden MJ, Mock MB. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung and Blood Institute. Am J Cardiol. 1984; 53:77C-81C.
2. Nobuyoshi M, Kimura T, Nosaka H, Mioka S, Ueno K, Yokoi H, Hamasaki N, Horiuchi H, Ohishi H. Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients. J Am Coll Cardiol. 1988;12: 616-623.
3. Serruys PW, Luijten HE, Beatt KJ, Geuskens R, de Feyter PJ, van den Brand M, Reiber JHC, ten Katen HJ, van Es GA, Hugenholtz PG. Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon: a quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months. Circulation. 1988;77: 361-371.
4. Forrester JS, Fishbein M, Helfant R, Fagin J. A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies. J Am Coll Cardiol. 1991;17:758-759.
5. Huber KC, Garrat KN, Schwartz RS, Edwards WD. Pathology of postinterventional coronary restenosis. In: Schwartz RS, ed. Coronary Restenosis. Cambridge, UK: Blackwell Scientific Publications; 1993:192-204
6. Clowes AW, Reidy MA, Clowes MM. Mechanisms of stenosis after arterial injury. Lab Invest. 1983;49:208-215.
7. Faxon DP, Sanborn TA, Weber VJ, Haudenschild C, Gottsman SB, McGovern WA, Ryan TJ. Restenosis following transluminal angioplasty in experimental atherosclerosis. Arteriosclerosis. 1984;4: 189-195.
8. Essed CE, van den Brand M, Becker AE. Transluminal coronary angioplasty and early restenosis: fibrocellular occlusion after wall laceration. Br Heart J. 1983;49:393-396.
9. Austin GE, Ratliff NB, Hollman J, Tabei S, Philip DF. Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol. 1985;6:369-375.
10. Ueda M, Becker AE, Fujimoto T. Pathological changes induced by repeated percutaneous transluminal angioplasty. Br Heart J. 1987; 58:635-643.
11. Schwartz SM, Campbell GR, Campbell JH. Replication of smooth muscle cells in vascular disease. Circ Res. 1986;58:427-444.
12. Kuro-o M, Nagai R, Nakahara K, Katoh H, Tsai RC, Tsuchimochi H, Yazaki Y, Ohkubo A, Takaku F. cDNA cloning of a myosin heavy chain isoform in embryonic smooth muscle and its expression during vascular development and in arteriosclerosis. J Biol Chem. 1991;266:3768-3773.
13. Kocher O, Gabbiani F, Gabbiani G, Reidy MA, Cokay MS, Peters H, Huttner I. Phenotypic features of smooth muscle cells during the evolution of experimental carotid artery intimal thickening: biochemical and morphologic studies. Lab Invest. 1991;65:459-470.
14. Chamley-Campbell J, Campbell GR, Ross R. The smooth muscle cell in culture. Physiol Rev. 1979;59:1-61.
15. Owens GK, Loeb L, Gordon D, Thompson MM. Expression of smooth muscle-specific alpha-isoactin in cultured vascular smooth muscle cells: relationship between growth and cyto-differentiation. J Cell Biol. 1986;102:343-352.
16. Rovner AS, Murphy RA, Owens GK. Expression of smooth muscle and nonmuscle myosin heavy chains in cultured vascular smooth muscle cells. J Biol Chem. 1986;261:14740-14745.
17. Babij P, Kawamoto S, White S, Adelstein RS, Periasamy M. Differential expression of SM1 and SM2 myosin isoforms in cultured vascular smooth muscle. Am J Physiol. 1992;262:C607-C6013.
18. Nagai R, Larson DT, Periasamy M. Characterization of a mammalian smooth muscle myosin heavy chain cDNA clone and its expression in various smooth muscle types. Proc Natl Acad Sci U S A. 1988;85:1047-1051.
19. Nagai R, Kuro-o M, Babij P, Periasamy M. Identification of two types of smooth muscle myosin heavy chain isoforms by cDNA cloning and immunoblot analysis. J Biol Chem. 1989;264:9734-9737.
20. Kuro-o M, Nagai R, Tsuchimochi H, Katoh H, Yazaki Y, Ohkubo A, Takaku F. Developmentally regulated expression of vascular smooth muscle myosin heavy chain isoforms. J Biol Chem. 1989; 264:18272-18275.
21. Aikawa M, Nalla Sivam P, Kuro-o M, Kimura K, Nakahara K, Takewaki S, Ueda M, Yamaguchi H, Yazaki Y, Periasamy M, Nagai R. Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis. Circ Res. 1993;73:1000-1012.
22. Owens GK. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev. 1995;75:487-517.
23. Rovner AS, Thompson MM, Murphy RA. Two different heavy chains are found in smooth muscle myosin. Am J Physiol. 1986;250: C861-870.
24. Miano JM, Cserjesi P, Ligon KL, Periasamy M, Olson EN. Smooth muscle myosin heavy chain exclusively marks the smooth muscle lineage during mouse embryogenesis. Circ Res. 1994;75:803-812.
25. Babij P, Periasamy M. Myosin heavy chain isoform diversity in smooth muscle is produced by differential RNA processing. J Mol Biol. 1989;210:673-679.
26. Kim HS, Aikawa M, Kimura K, Kuro-o M, Nakahara K, Suzuki T, Katoh H, Okamoto E, Yazaki Y, Nagai R. Ductus arteriosus: advanced differentiation of smooth muscle cells demonstrated by myosin heavy chain isoform expression in rabbits. Circulation. 1993; 88:1804-1810.
27. Okamoto E, Suzuki T, Aikawa M, Imataka K, Fujii J, Kuro-o M, Nakahara K, Hasegawa K, Yazaki Y, Nagai R. Diversity of the synthetic-state smooth muscle cells proliferating in mechanically and hemodynamically injured rabbit arteries. Lab Invest. 1996;74: 120-128.
28. Kawamoto S, Adelstein RS. Chicken nonmuscle myosin heavy chains: differential expression of two mRNAs and evidence for two different polypeptides. J Cell Biol. 1991;112:915-924.
29. Simons M, Wang M, McBride OW, Kawamoto S, Yamanaka K, Gdula D, Adelstein RS, Weir L. Human nonmuscle myosin heavy chains are encoded by two genes located on different chromosomes. Circ Res. 1991;69:530-539.
30. Okamoto E, Imataka K, Fujii J, Kuro-o M, Nakahara K, Nishimura H, Yazaki Y, Nagai R. Heterogeneity in smooth muscle cell population accumulating in the neointimas and the media of poststenotic dilatation of the rabbit carotid artery. Biochem Biophys Res Commun. 1992;185:459-464.
31. Garrat KN, Edwards WD. Directional atherectomy: Histopathologic studies. In: Holmes DR Jr, Garrat KN, eds. Atherectomy. Cambridge, UK: Blackwell Scientific Publications; 1992:106-131.
32. Shimada H, Shimizu T, Kuwayama H, Suzuki M, Nagai R, Morii H. Immunocytochemical localization of 155 kDa myosin light chain kinase and myosin heavy chain in bovine brain. Brain Res. 1995; 682:212-214.
33. Skalli O, Rospraz P, Trzeciak K, Benzonana G, Gillesen D, Gabbiani G. A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation. J Cell Biol. 1986;103:2787-2796.
34. Frid MG, Printesva OY, Chiavegato A, Faggin E, Scatena M, Koteliansky VE, Pauletto P, Glukhova MA, Sartore S. Myosin heavy-chain isoform composition and distribution in developing and adult human aortic smooth muscle. J Vasc Res. 1993;30: 279-292.
35. Suzuki J, Isobe M, Aikawa M, Kawauchi M, Shiojima I, Kobayashi N, Tojo A, Kimura K, Nishikawa T, Sakai T, Sekiguchi M, Yazaki Y, Nagai R. Nonmuscle and smooth muscle myosin heavy chain expression in rejected cardiac allografts: a study in rat and monkey models. Circulation. 1996;94:1118-1124.
36. Woodcock-Mitchell J, Mitchell JJ, Low RB, Kieny M, Sengel P, Rubbia L, Scalli O, Jackson B, Gabbiani G. Alpha-smooth muscle actin is transiently expressed in embryonic rat cardiac and skeletal muscles. Differentiation. 1988;39:161-166.
37. Gabbiani G. The biology of the myofibroblast. Kidney Int. 1992;41: 531-532.
38. Hiroi J, Kimura K, Aikawa M, Tojo A, Suzuki Y, Nagamatsu T, Omata M, Yazaki Y, Nagai R. Expression of a nonmuscle myosin heavy chain in glomerular cells differentiates various types of glomerular disease in rats. Kidney Int. 1996;49:1231-1241.
39. Scott NA, Cipolla GD, Ross CE, Dunn B, Martin FH, Simonet L, Wilcox JN. Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation. 1996;93:2178-2187.
40. Ueda M, Becker AE, Tsukada T, Numano F, Fujimoto T. Fibrocellular tissue response after percutaneous transluminal coronary angioplasty: an immunohistochemical analysis of the cellular composition. Circulation. 1991;83:1327-1332.
41. Ueda M, Becker AE, Naruko T, Kojima A. Smooth muscle cell de-differentiation is fundamental change preceding wound healing after percutaneous transluminal coronary angioplasty in humans. Coron Artery Dis. 1995;6:71-81.
42. Campbell JH, Campbell GR. Endothelial cell influences on vascular smooth muscle cell phenotype. Annu Rev Physiol. 1986;48: 295-306.
43. Zanellato AM, Borrione AC, Tonello M, Scannapieco G, Pauletto P, Sartore S. Myosin isoform expression and smooth muscle cell heterogeneity in normal and atherosclerotic rabbit aorta. Arteriosclerosis. 1990;10:996-1009.
44. Garrat KN, Edwards WD, Kaufman UP, Vlietstra RE, Holmes DR Jr. Differential histopathology of primary atherosclerotic and restenotic lesions in coronary arteries and saphenous vein bypass grafts: analysis of tissue obtained from 73 patients by directional atherectomy. J Am Coll Cardiol. 1991;17:442-448.
45. Knecht DA, Loomis WF. Antisense RNA inactivation of myosin heavy chain gene expression in Dictyosterium discoideum. Science. 1987;236:1081-1086.
46. De Lozanne A, Spudich JA. Disruption of the Dictyosterium myosin heavy chain gene by homologous recombination. Science. 1987;236: 1086-1091.
47. Grainger DJ, Hesketh TR, Metcalfe JC, Weissberg PL. A large accumulation of non-muscle myosin occurs at first entry into M phase in rat vascular smooth-muscle cells. Biochem J. 1991;277: 145-151.
48. Leclerc G, Isner JM, Kearney M, Simons M, Safian RD, Baim DS, Weir L. Evidence implicating nonmuscle myosin in restenosis: use of in situ hybridization to analyze human vascular lesions obtained by directional atherectomy. Circulation. 1992;85:543-553.
49. Simons M, Leclerc G, Safian RD, Isner JM, Weir L, Baim DS. Relation between activated smooth-muscle cells in coronary-artery lesions and restenosis after atherectomy. N Engl J Med. 1993;328: 608-613.
50. Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury, I: smooth muscle growth in the absence of endothelium. Lab Invest. 1983;49:327-333.
51. Hanke H, Strohschneider T, Oberhoff M, Betz E, Karsch K. Time course of smooth muscle cell proliferation in the intima and the media of arteries following experimental angioplasty. Circ Res. 1990;67:651-659.
52. Libby P, Schwartz D, Brogi E, Tanaka H, Clinton SK. A cascade model for restenosis: a special case of atherosclerosis progression. Circulation. 1992;86(suppl III):III-47-III-52.
53. Ferrell M, Fuster V, Gold HK, Chesebro JH. A dilemma for the 1990s: choosing appropriate experimental animal model for the prevention of restenosis. Circulation. 1992;85:1630-1631.
54. Jackson CL. Animal models of restenosis. Trends Cardiovasc Med. 1994;4:122-130.
55. Holycross BJ, Blank RS, Thompson MM, Peach MJ, Owens GK. Platelet-derived growth factor-BB-induced suppression of smooth muscle cell differentiation. Circ Res. 1992;71:1525-1532.
56. Watanabe M, Sakomura Y, Kurabayashi M, Manabe I, Aikawa M, Kuro-o M, Suzuki T, Yazaki Y, Nagai R. Structure and characterization of the 5′-flanking region of the mouse smooth muscle myosin heavy chain (SM1/2) gene. Circ Res. 1996;78:978-989.
57. Katoh Y, Loukianov E, Kopras E, Zilberman A, Periasamy M. Identification of functional promotor elements in the rabbit smooth muscle myosin heavy chain gene. J Biol Chem. 1994;48:305380-30545.
58. Manabe I, Aikawa M, Watanabe M, Shimomura Y, Sakomura Y, Nagai R. Transcriptional regulation of a nonmuscle-type myosin heavy chain (SMemb) in smooth muscle cell. Circulation. 1994; 90(suppl I):I-144. Abstract.